Mirati Therapeutics, Inc. 4
4 · Mirati Therapeutics, Inc. · Filed Jan 30, 2017
Insider Transaction Report
Form 4
LEMASTERS CHRISTOPHER C.
EVP, Chief Business Officer
Transactions
- Award
Option Grant (Right to Buy)
2017-01-26+11,250→ 11,250 totalExercise: $5.40Exp: 2027-01-25→ Common Stock (11,250 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.